Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Secondary and primary thrombocythemia]

L Judkiewicz1

  • 1Samodzielnej Pracowni Zaburzeń Krzepniecia Krwi Katedry Diagnostyki Laboratoryjnej A.M., Lodzi.

Acta Haematologica Polonica
|January 1, 1993
PubMed
Summary

Reactive thrombocytosis involves high platelet counts due to other diseases, while essential thrombocythemia is a bone marrow disorder causing excess platelets and potential bleeding or clotting risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Low molecular weight heparins in prophylaxis and treatment of thromboembolic disorders].

Acta haematologica Polonica·1994
Same author

[Role of fibrinogen in cardiovascular diseases].

Acta haematologica Polonica·1994
Same author

Abnormal degradation of red cell membrane proteins in diabetes.

Cytobios·1993
Same author

[Familial occurrence of Glanzmann thrombasthenia].

Polski tygodnik lekarski (Warsaw, Poland : 1960)·1992
Same author

[Standard heparin and low molecular weight heparins].

Acta haematologica Polonica·1992
Same author

Consequences of the presence of elongated variant of the major transmembrane protein (Band 3 protein) in the human erythrocyte.

Clinica chimica acta; international journal of clinical chemistry·1991

Area of Science:

  • Hematology
  • Oncology
  • Internal Medicine

Context:

  • Reactive thrombocytosis presents as an elevated platelet count secondary to various conditions including infections, inflammation, and neoplastic states.
  • Essential thrombocythemia is a myeloproliferative neoplasm characterized by excessive platelet production originating from megakaryocytes.

Purpose:

  • To differentiate reactive thrombocytosis from essential thrombocythemia.
  • To outline the distinct pathophysiological mechanisms and clinical features of each condition.

Summary:

  • Reactive thrombocytosis is a reactive increase in platelets linked to underlying diseases.
  • Essential thrombocythemia involves abnormal megakaryocyte proliferation, leading to high platelet counts, splenomegaly, and thrombotic or hemorrhagic complications.

Impact:

  • Clarifies diagnostic distinctions between reactive and essential thrombocytosis.
  • Provides foundational knowledge for understanding platelet count abnormalities and their clinical significance in hematologic disorders.

Related Experiment Videos